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Leishmaniasis caused by Leishmania sp. has a wide range of manifestations from cutaneous to the deadly visceral form. They
shuttle between the invertebrate and vertebrate hosts as promastigotes and amastigotes having adaptations for subverting host
immune responses. Parasite-specific glycoconjugates have served as important determinants influencing parasite recognition,
internalization, differentiation, multiplication, and virulence. Despite the steady progress in the field of parasite glycobiology,
sialobiology has been a less traversed domain of research in leishmaniasis. The present paper focuses on identification,
characterization, and differential distribution of sialoglycotope having the linkage-specific 9-O-acetylated sialic acid in
promastigotes of different Leishmania sp. causing different clinical ramifications emphasizing possible role of these sialoglycotopes
in infectivity, virulence, nitric oxide resistance, and host modulation in Leishmania spp. asserting them to be important molecules
influencing parasite biology.
1. Introduction
Human beings are often infested by parasites that manip-
ulate the milieu of the host causing several pathological
manifestations. Today one of the biggest risks to man are
infectious/parasitic diseases. Such parasites include obligate
intracellular kinetoplastids, of which Leishmania comprising
21 diverse species causes a range of disease manifestations
from cutaneous leishmaniasis (CL) to lethal (if untreated)
visceral leishmaniasis (VL; also known as kala-azar). Less
recurrent forms of the disease include mucosal leishmaniasis,
diffuse CL with nodular lesions and post-kala-azar dermal
(PKDL) occurring as a followup to VL. L. infantum or L.
donovani causes VL, characterized by systemic infection of
the reticuloendothelial system. The cutaneous form is caused
by L. major, L. tropica, and L. aethiopica in the Old World;
L. mexicana, L. braziliensis, and L. amazonensis in the New
World [1–4]. The present scenario of leishmaniasis is severe,
being endemic in 88 countries affecting approximately 12
million people worldwide. The disease has an incidence of
1.5 to 2 million new cases every year. VL has an esti-
mated global incidence of 200,000–500,000, and CL shows
a prevalence of more than 5 million cases worldwide
(http://apps.who.int/tdr/). The situation is all the more
alarming in India and Sudan where recent epidemics have
caused 100,000 deaths [5–8]. Considering the disaster to
life, knowledge about Leishmania biology, disease pathogen-
esis, and host-parasite relationship encompassing numerous
molecular and biochemical interactions is the need of the
hour. Already many parasite-surface glycoconjugates and
other factors influencing parasite biology with or within
the host cell are reported. Could we find many more? In
spite of many potential roles of diverse forms of sialic acids
in different cellular processes, sialoglycobiology is a less
explored area in leishmaniasis [9–17]. Could elucidation of
sialoglycobiology save us from this grave situation? Hence,
this review hasmade amodest attempt to assemble the obser-
vations on the sialobiology of Leishmania sp. highlighting
their importance in leishmaniasis.
2 Molecular Biology International
2. Biology of Leishmania: Key to Different
Manipulative Strategies
Leishmania is a digenetic parasite completing its life cycle
within human beings and female sand-flies (e.g., Phle-
botomus species in the Old World, Lutzomyia species in
the New World). The parasite while shuttling between the
hosts differentiates into different flagellated (promastigotes)
and aflagellated forms (amastigotes). The amastigotes are
taken up by female sand flies, within whose midgut they
differentiate into motile procyclic forms that transform into
the nectomonads [18]. After their escape they attach to the
sand-fly gut-epithelium [19]. The successful multiplication,
predominance and infectivity of both these stages within
the respective host require several adaptive modifications
[7]. The mode of attachment may be through one major
glycan molecule lipophosphoglycan (LPG), as evidenced in
L. major, or may be mediated by receptor-ligand interac-
tion [20–25]. The infective metacyclic promastigotes are
transmitted into humans. This constant differentiation all
throughout the life cycle forces the parasite to acquire special
adaptive mechanisms by exploiting different parasite-derived
moieties. Thus knowledge of the parasite topology becomes
important to understand its course within the host that could
probably shed light on the identification of novel targets for
diagnosis and therapy.
3. Glycoconjugates of Leishmania and
Their Significance
Diverse range of glycoconjugates involved in recognition,
attachment, internalization, and differentiation in L. adleri
[26], L. major [27], L. mexicana [28], L. tarentolae [29],
and L. donovani [30–32] have been documented. Shedding
and secretion of many Leishmania-derived glycoconjugates
like acid phosphatase, proteophosphoglycans and phospho-
glycans and their role in virulence and differentiation is
known [33–37]. The role of macrophage mannosyl fucosyl
receptor in invasion of L. donovani promastigotes indicates
the presence of these sugars on parasite surface [38]. LPG,
glycoprotein 63 (gp63), a zinc metalloprotease increases
infectivity of L. major and L. amazonensis within the host
[39, 40]. Additionally, gp63 also alters host signaling caus-
ing intracellular survival of parasites by cleaving activated
tyrosine phosphatases of the macrophage and controls the
parasite burden within dendritic cells [41–44]. LPG plays
an important role as a regulator of nitric oxide (NO) and a
modulator of host responses that affects intracellular survival
[37, 45, 46]. It reduces the activity of protein kinase C and
protein tyrosine phosphatase accompanied with decrease in
levels of IFN-γ, IL-12, NO, and reactive oxygen intermediates
produced bymacrophages and increased production of IL-10
and TGF-β by T cells [47]. Additionally, glycoinositolphos-
pholipids also plays a potent role in inhibition of NO in
murine macrophages [34]. Hence, these glycoconjugates are
considered as important markers of virulence. Differences in
the distribution of proteophosphoglycans on promastigotes
and amastigotes in pentavalent antimony resistant and
sensitive clinical isolates suggest the implications of surface
topology in determining the clinical outcome of the disease
[48]. Therefore glycoconjugates and their association with
leishmania have always instigated the scientific community
to unravel their importance.
4. Sialic Acids and Parasite
Sialic acids or N-acetylneuraminic acid (Neu5Ac or SA) are
nine carbon sugar molecules comprising of more than 50
forms based on modifications of the amino and hydroxyl
group [11, 16, 17, 49]. The predominantly occurring forms
are the O-acetylated SA (at C-7/8/9) forming O-acetylated
sialoglycoconjugates [12–15, 49, 50]. It is usually present
at the terminal end of glycoconjugates and affects different
cell-mediated physiological processes. The parasites being
manipulative often utilize SA for mediating different facets
necessary for establishing successful infection, like recogni-
tion, adhesion, infectivity and survival. Trypanosoma cruzi,
causing chagas disease has a cell surface decorated with SA-
bearing mucin like structures forming a negatively charged
coat which prevents killing of the infective trypomastigotes
by human anti-α-galactosyl antibodies [51]. The presence
of tran-sialidase in trypanosomes is a landmark discovery
in the domain of sialoglycobiology. This unique enzyme
cleaves SA from host-derived glycans and incorporates it into
mucin-like molecules on their surface without the need of
metabolic energy; hence, serve as virulence factors [51, 52].
These sialylated structures also serve as ligands for siglecs
(sialic acid binding immunoglobulin-like lectins) naturally
present on different hematopoietic cells [53, 54]. A majority
of molecules like reticulocyte binding protein homologue
used by the merozoites of Plasmodium falciparum include
terminal SA containing glycans joined to glycophorin on
the host cell [55, 56]. Encystation of the infective cyst-
stage in Entamoeba histolytica involves distinct sialoglycans
indicating the association of SA [57]. Toxoplasma gondii,
the causative agent of toxoplasmosis demonstrated uptake
of fetuin (a sialoglycoprotein) by tachyzoites, signifying that
sialoglycans are inevitable for the maintenance of their
lifecycle [58]. Therefore the integration of SA with parasites
has always suggested their probable implications as effective
drug targets.
5. Sialic Acids on L. donovani
Over the past decade, we have demonstrated the presence
of sialic acids and distinct sialoglycoproteins on promastig-
otes and amastigotes of L. donovani using Sambucus nigra
agglutinin (SNA) and Maackia amurensis agglutinin (MAA)
having preferential binding specificity towards α2-6 and α2-
3 SA, respectively. The predominance of α2-6 linked SA on
parasites suggests their stage-specific association indicating
their probable implication in parasite biology [59–61]. The
complex pattern of binding of L. donovani with different
recombinant siglecs provides evidence in support of these
sialoglycotopes serving as important determinants for recog-
nition. Additionally, we have also demonstrated the presence
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of 9-O-acetylated sialic acid (9-O-AcSA) and distinct 9-O-
acetylated sialoglycoproteins (9-O-AcSGPs) on L. donovani
using a snail lectin, Achatinin-H [59, 61, 62]. Interestingly,
the amastigotes of L. donovani exhibit an unusual derivative
of SA, N-glycolylneuraminic acid (Neu5Gc), absent on
promastigotes. Neu5Gc is the evolutionary missing link
present in the apes while its absence has been documented
in humans due to a mutation in the gene coding CMP-N-
acetylneuraminic acid hydroxylase for its biosynthesis [63].
However, increased presence of Neu5Gc in various forms
of human cancers and its association with certain parasites
like Nippostrongylus brasiliensis makes it a relevant target for
detailed exploration [64, 65]. The occurrence of Neu5Gc on
amastigotes and the evidence of a completely new set of
sialoglycoprotein bands in Western blot analysis with SNA
and MAA using amastigotes membrane fraction suggest that
probably these parasites are capable of accommodating new
molecule which could influence their biology within the
host cells. Thus the intracellular pools within the host cells
could serve as the source of these molecules. Since Neu5Gc is
absent in healthy humans, the presence of this sugar indicates
the interplay of some biochemical modification that occurs
during the transformation of promastigotes to amastigotes.
However, the exact mechanism remains to be investigated.
Elucidation of its functional significance in stage-specific
Leishmania biology could probably make it a novel target for
therapy. Such studies are currently ongoing.
6. Acquisition of Sialic Acids by Leishmania
The occurrence of SA at the termini of glycoconjugates
on the parasite surface obviously haunts us about the
mechanism of their acquisition. SAmay either be synthesized
de novo or may be transferred with the help of transsialidase
or could also be scavenged from other external sources.
Whatever the mechanism may be, it employs a specialized
system that demands detailed exploration and varies in
different parasites. The pivotal role in biosynthesis of SA
is played by UDP-GlcNAc 2-epimerase which catalyzes the
first step, hence its presence or absence provides direct
evidence in favor of the sialic acid synthesis machinery.
The absence of the activity of UDP-GlcNAc 2-epimerase in
Leishmania rules out the possible presence of biosynthetic
machinery in it. The culture medium containing fetal calf
serum (FCS) exhibits a few distinct serum α2-6- and α2-3-
linked sialoglycoproteins analogous to those present on the
promastigotes as visualized by binding with SNA (130, 123,
90, and 70 kDa) and MAA (123, 90, and 70 kDa) [59, 60].
These observations provide probable evidence in support
of the direct transfer of SA containing glycoconjugates by
polyanionic adsorption and their incorporation in the gly-
cocalyx comprising LPG. Decrease binding of both the sialic
acid binding lectins with promastigotes, grown in reduced
serum concentration, corroborates the theory of borrowing
of SA from environment to reimburse the deficient status.
Speculations suggest that this transfer of sialoglycoconju-
gates could occur either wholly or partially by the aid of
enzymatic fragmentation which would ultimately fit within
the complex outer glycocalyx of the parasite. However, the
exact mechanism of the transfer remains to be investigated.
The incorporation of SA-modified glycoconjugates under
different growth conditionsmay have a probable effect on the
surface architecture of the parasite. It may be possible that
the incorporated sialoglycoconjugates mask some moieties
or modify them leading to newer conformations being
displayed on the surface which could potentially serve as
more stringent markers of virulence. Alternative possibility
could be that changes in SA opsonization reflect alteration in
other cell surface molecules that are required for virulence.
However, whatever may be the consequences the exact
interplay of these molecules on the parasite surface remains
to be investigated.
Acquisition of SA in the absence of de novo SA biosyn-
thesis enzyme machinery is also achieved by transsialidases
that not only cleave SA from host glycoconjugates but also
transfers it on itself [52, 60]. Another mode of acquisition
could be the transfer of SA from CMP-SA acting as the
nucleotide sugar donor by serum or ectosialyltransferases on
the parasite surface glycoconjugates. However, the evidence
of the occurrence of serum CMP-SA is still lacking, hence
the role of ectosialyltransferases is doubtful and requires
elaborate study. Under experimental conditions, we could
not detect 9-O-AcSGPs in FCS, possibly due their minimal
presence. 9-O-acetylation of SA occurs due to the fine
balance of four key enzymes, namely, O-acetyl transferases,
sialyltransferases, esterases, and sialidase [17]. Although,
to date the occurrence of these enzymes is lacking in the
Leishmania, but one cannot completely rule out the fact.
Moreover the presence of inactive enzymes cannot be ruled
out and is a domain of elaborate future research. Recently
reported genome sequences of L. major, L. braziliensis, and
L. infantum show conserved gene sequences [66]. N-acetyl
transferase producing N1-acetylspermidine in L. amazo-
nensis indicates the presence of enzymes for acetylation
[67]. However, any such claim for the presence of O-
acetyltransferase requires the identification of the respective
genes which at present is lacking. Direct analogies correlating
the transfer of sialoglycoproteins from the serum demands
elaborate proteomic characterization of surface proteins on
promastigotes and are a subject of future research.
7. Differential Distribution of Sialic
Acids on Promastigotes of Virulent and
Avirulent Leishmania sp.
Interestingly, in our study four virulent strains of L. donovani
(AG83, GE1, NS1, and NS2) and six other virulent strains
K27 (L. tropica), JISH118 (L. major), LV4 (L. mexicana),
LV81 (L. amazonensis), L280 (L. braziliensis), MON29 (L.
infantum) demonstrate a differential distribution of SA
[68, 69]. All virulent strains reveal higher presence of total
SA content as compared to avirulent UR6 strain ([69–72],
Figure 1(a)). The strain UR6 (MHOM/IN/78/UR6) failed to
induce visceral infection by intracardiac inoculation and was
cultured accordingly. Therefore, UR6 has been considered as
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Figure 1: Identification of sialic acids on promastigotes of different Leishmania sp. (a) Fluorimetric estimation of enhanced sialic acids on
promastigotes of virulent Leishmania sp. as compared to their minimal presence on avirulent UR6. Results are the mean ± S.D. where, ∗
(asterisk) means P < 0.01 as compared to UR6 were performed using as Graph-Pad Prism statistics software (Graph-Pad Software Inc., San
Diego, CA, USA) as described in [68, 69]. (b) Differential distribution of 9-O-AcSA on promastigotes as detected fluorimetrically. Results
are expressed as 9-O-AcSA (%), defined as the percent of 9-O-AcSA present in the total sialic acid content (μg/5 × 108 promastigotes) as
described in [68, 69]. (c) Representative HPLC chromatogram of sialic acids and its derivatives on promastigotes of a few virulent Leishmania
sp. and avirulent UR6 of L. donovani (reproduced and adapted from [68, 69] with permission of the publishers, the Cambridge University
Press, and Oxford University Press).
“avirulent” strain owing to its poor ability to infect and mul-
tiply within macrophages [70, 71]. Virulent AG83 revealed
a 15-fold higher presence of total SA content as compared
to avirulent UR6. Amongst six other virulent strains of
Leishmania sp., K27 shows highest amount of total SA as
compared to the least presence on LV81 (Figure 1(a)). Our
observations indicate a specific order of SA predominance
as follows: K27 > JISH118 > L280 > MON29 > LV4 > LV81.
Furthermore, 9-O-AcSA (%) demonstrates a similar trend
of distribution in all the virulent strains indicating their
differential species-specific distribution showing its minimal
presence on avirulent UR6 (Figure 1(b)). Accordingly, K27,
JISH118, L280, and MON29 are categorized as high
SA-containing strains having enhanced 9-O-AcSA (9-
O-AcSAhigh) whereas LV4 and LV81 demonstrate con-
siderably reduced SA. Liberated SA from K27 shows
comigrating peaks corresponding to Neu5Ac, Ne5Gc,
N-acetyl-7/8/9-O-acetylneuraminic acid, and N-glycolyl-
9-O-acetylneuraminic acid (Tables 1 and 2, Figure 1(c)).
LV4 and LV81 having reduced SA show similar patterns.
Complete absence of the peak corresponding to 9-O-AcSA
on avirulent UR6, confirms its undetectable presence
(Figure 1(c), Table 1). Neu5Gc is detected on UR6, which is
strongly bound to the surface, as after extensive washing of
Molecular Biology International 5
Table 1: Quantitative analysis of sialic acids by fluorimetric-HPLC.
Strain Designation and species Disease form
HPLC of promastigotes (μg/2× 109)$
Neu5Ac Neu5Gc Neu5,9Ac2
AG83 MHOM/IN/83/AG83 (L. donovani) Visceral 0.80 ND 7.7% of total sialic acid
UR6 MHOM/IN/78/UR6 (L. donovani)
Avirulent
(incapable of infection)
0.055 0.28 ND∗
K27 MHOM/SU/74/K27 (L. tropica) Cutaneous 15.12 9.76 5.16
LV4 MNYC/BZ/62/M379 (L. Mexicana) Cutaneous 0.72 0.08 ND
LV81 MORY/BR/72/M1824 (L. amazonensis) Diffuse 0.12 Trace amount ND
∗ND, not detectable.
$The quantitative measurement of the different derivatives of sialic acids has been represented by normalizing the cell number (2×109) and amount expressed
as μg for the ease of comparison. Under the actual experimental conditions, analysis of K27, LV4, and LV81 was performed using 5 × 109 promastigotes.
Similarly, the amount of sialic acids estimated on AG83 and UR6 promastigotes was detected in terms of ng under the specified assay conditions
(reproduced and adapted from [59, 68, 69] with permission from publishers, the Oxford University Press, and Cambridge University press.)
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Cambridge University Press, and Oxford University Press).
promastigotes, the washes show negligible amounts of SA.
The topology of parasites cannot be decoded without the
knowledge of different forms of molecules present on them
as specific chemical modifications may influence their bio-
logical function; hence there is need for the assessment of the
linkage specificity of SA. Predominance of α2-6-linked SA
in all virulent strains demonstrates higher binding with SNA
and recombinant siglec-2 having a preferential specificity for
α2-6 linked SA (Figure 2(a)) corresponding to the presence
of distinct sialoglycoproteins (α2-6- and α2-3-linked) on dif-
ferent promastigote membranes (Figure 2(b)) as compared
to UR6. All virulent strains demonstrate higher binding with
Achatinin-H as compared to UR6 and this binding is almost
nullified when the promastigotes were de-O-acetylated
using recombinant O-acetyl esterase from Haemophilus
influenzae ([73], Figures 3(a) and 3(b)). The reagent used is
a re-combinant form of 9-O-acetyl hemagglutinin esterase of
in-fluenza C virus. It has been originally cloned in an SV40
vector [73] to construct a gene consisting of the influenza
C virus HE1 domain fused to the eGFP gene. The esterase
specifically cleaves the 9-O-acetyl groups. Enhanced number
of receptors (9-O-acetylated sialoglycotopes) is found on all
different virulent promastigotes (Figure 3(c)); K27 having
the highest (1.94 × 107) and LV81 with lowest number
(1.42× 104) of receptors. In contrast, avirulent UR6 shows a
basal level binding signifying that this unique sialoglycotope
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Table 2: Quantitative analysis of sialic acids by GC/MS.
Derivative (μg/5 × 109) L. tropica (K27)
Retention time (min) RNeu5Ac Mass fragment ions A-F (m/z)
Neu5Ac 14.10 1.00 668, 624, 478, 400, 317, 298, 173
Neu5,9Ac2 15.80 1.12 638, 594, 478, 400, 317, 298, 175
Neu5Gc 24.60 1.74 756, 712, 566, 488, 386, 317, 261
L. amazonensis (LV81)
Neu5Ac 14.80 1.00 668, 624, 478, 400, 317, 298, 173
L. mexicana (LV4)
Neu5Ac 14.80 1.00 668, 624, 478, 400, 317, 298, 173
Neu5Gc 25.60 1.74 756, 712, 566, 488, 386, 317, 261
Reproduced and adapted from [68] with permission from publishers, and the Oxford University Press.
is a potential marker for virulent strains. Additionally,
the presence of distinct 9-O-acetylated sialoglycoproteins
on different Leishmania sp. corroborates similar finding
(Figure 3(d)). Although we have provided strong evidence
in support of the presence of 9-O-AcSA and linkage specific
SA, there are a few limitations in this field of work due to
lack of reagents/probes. First of all, there are only a few
lectins which can bind only to linkage-specific 9-O-AcSA.
Achatinin-H, in spite of having a narrow binding specificity
towards 9-O-AcSA derivatives α2-6 linked to subterminal
N-acetylgalactosamine (9-O-AcSAα2-6GalNAc), binds only
to the terminal modifications on glycoproteins [59, 61, 62].
Hence, sialoglycolipids having possible 9-O-AcSA escapes
detection. Additionally, the labile nature of O-acetylation
due to sensitivity towards alkaline pH and high temperature
which are two main inherent problems also restricts
the use of many other chemical/analytical methods for
elaborate study. Besides under physiological conditions,
O-acetyl esters from C7 to C8 spontaneously migrate to
C9-OH group unless already substituted. Therefore, specific
identification of O-acetylation at 7, 8, or 9 position is quite
difficult. Accordingly, the binding of Achatinin-H towards 7-
O- or/and 8-O-Ac sialic acids cannot be excluded. Therefore,
presence of such linkages in O-acetylated sialoglycoproteins
may be present on parasites. Furthermore, unavailability
of analytical tools with distinct binding affinity for 9-O-
acetylated α2-3 and/or α2-8 linked SA limits our study.
Accordingly, the existence of 9-O-acetylated α2-3 and/or
α2-8 linked SA cannot be ruled out. Additionally, the lack
of chemically synthesized inhibitor for the O-acetylated
sialoglycotope forces the use of only bovine submandibular
mucin containing maximal amount of 9-O-AcSA, which
poses another limitation. Taking into consideration the
lim-itations of the probes, there remains scope for further
ex-ploration of the promastigote surface. However, it may
be envisaged that a varying distribution of SA on various
virulent Leishmania sp. causing different forms of the disease
probably imply their relevance to pathogenesis. In contrast,
minimal or undetectable presence of SA especially 9-O-AcSA
on avirulent UR6 also provides evidence in signifying their
probable association with virulence. Hence we hypothesize
this 9-O-acetylated sialoglycotope to be one of the many
existing markers of virulence in leishmania biology.
8. Role of 9-O-AcSA in Entry of Virulent
Promastigotes within Host Macrophages
Recognition and entry of parasites within the host cell
is the first step towards the establishment of a successful
infection. This section highlights the role of 9-O-AcSA on
virulent promastigotes in infectivity [68]. The 9-O-AcSAs on
virulent promastigotes modulate macrophage-promastigote
interactions. The entry of virulent AG83 promastigotes via
9-O-AcSA is maximal at 37◦C as compared to 4◦C and
25◦C, respectively, indicating the influence of temperature.
The phagocytic index exhibits a linear rise with vary-
ing promastigote :macrophage ratio and demonstrates 98%
internalization indicating phagocytic saturation beyond two
hours. Increased phagocytic index for virulent promastigotes
(Figure 4(b)) compared to avirulent UR6 signify its viru-
lence. The enhanced internalization of virulent promastig-
otes indicates the influence of 9-O-AcSA in promastigote-
entry. De-O-acetylated virulent promastigotes demonstrate
a substantial decrease in infectivity (%) and phagocytic
index exhibiting a good correlation with each other, further
proving the significance of 9-O-AcSA in parasite-entry
(Figures 4(a)–4(c)). Desialylated virulent promastigotes also
exhibit reduced infection suggesting the contribution of SA
in parasite entry to some extent (Figure 4(c)).
Metacyclogenesis is the process of differentiation of
the infective metacyclic promastigotes that determines the
virulence of a particular Leishmania sp. [74, 75]. The
increased proportion of metacyclic promastigotes in a 5
to 6 day stationary phase culture decides the effective
virulence of a particular strain. Distribution of different
virulence factors (LPG and gp63) on virulent parasites and
their absence in avirulent UR6 hints towards their role in
metacyclogenesis [75–77]. Different structural modifications
in the glycan composition of LPG play an important role
in altered metacyclogenesis of L. major and L. donovani
[75–77]. Reduced metacyclogenesis in avirulent UR6 shows
decreased proportion of FSClow metacyclic population (R1)
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of virulent and avirulent promastigotes. The binding of FITC-Achatinin-H with promastigotes AG83 and UR6 was analyzed before and
after de-O-acetylation followed by subsequent desialylation using sialidase from Arthrobacter ureafaciens by flow cytometry as described in
[68, 69]. (b) Demonstration of 9-O-AcSA by ELISA. Membrane lysates of the respective strains were incubated separately with Achatinin-H
and the binding was recorded colorimetrically as described in [68]. (c) Increased number of surface 9-O-AcSA containing sialoglycotope
on AG83 and their minimal distribution on UR6 promastigotes. The receptors (O-acetylated sialoglycoproteins) on AG83 were estimated
by determining the specific binding of AG83 (black diamond) by subtracting the nonspecific binding (black square) using excess unlabelled
Achatinin-H from total binding (white square) . UR6 (white diamond) evidenced a basal level of specific binding. Inset: scatchard plot
showing the binding of 125I-Achatinin-H with 9-O-AcSA containing sialoglycoproteins present on AG83 promastigotes as described in [69].
(d) Presence of 9-O-acetylated sialoglycoproteins as detected by Western blot on virulent promastigotes of different Leishmania sp. The
specificity of binding was examined by using membrane proteins of de-O-acetylated promastigotes as described in [68, 69] (reproduced and
adapted from [68, 69] with permission of the publishers, Oxford University Press, and Cambridge University Press, resp.).
in stationary phase as compared to their higher proportion
in virulent AG83, indicating reduced metacyclogenesis in
avirulent strains (Figure 4(d)). Interestingly, the proportion
of metacyclics increases from logarithmic to stationary phase
cultures in virulent AG83. In contrast in UR6, there is no
significant increase in the proportion of metacyclics in the
different phases of culture. Higher proportions of metacyclic
population of AG83 show enhanced distribution of 9-O-
AcSA as compared to their negligible presence on metacylics
of UR6 (Figure 4(e)). This observation demonstrated that
not only there was reduced proportion of metacyclics in
avirulent UR6 but even this small proportion showed min-
imal presence of 9-O-AcSA. This hints towards a probable
link, between metacyclogenesis and the presence of 9-O-
AcSA. The direct influence of 9-O-AcSA in the process of
metacyclogenesis remains to be investigated and is a matter
of future research.
9. Enhanced 9-O-AcSA in Different Leishmania
sp., Nitric Oxide (NO) Resistance, and
Modulation of Host Responses
The presence of SA especially 9-O-AcSA on virulent Leishma-
nia sp., its role in entry of promastigotes into macrophages
and their undetectable presence on avirulent UR6 intimates
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their significance in parasite biology. Being intracellular
obligatory parasites they have the ability to withstand the
oxidative stress exerted by the host [33, 34, 37, 45, 46].
Promastigotes of all the six virulent strains demonstrate a
differential viability when exposed to NaNO2, indicating
their inherent ability to resist NO for combating the host
defense system. A decrease in viability of de-O-acetylated
parasites (Figures 5(a) and 5(b)) indicates a probable asso-
ciation of NO-resistance and 9-O-AcSA. Thus removal of O-
acetyl group by deacetylation hints the possible role of this
particular modification of SA. Desialylated promastigotes ex-
hibit an additional reduction in survivability. The parasite
(LV81) with least amount of SA and 9-O-AcSA demonstrates
unchanged viability after exposure toNObefore and after de-
O-acetylation and desialylation suggesting a species-specific
role of the 9-O-acetylated sialoglycotope (Figure 5(c)). In-
fection of de-O-acetylated promastigotes of 9-O-AcSAhigh
strains show a maximal reduction in the number of intra-
cellular parasites (Figures 5(d) and 5(e)). This indicates
that 9-O-AcSA influence proliferation of promastigotes after
which they are subjected to probable intracellular killing
in the absence of the 9-O-acetylated sialoglyctope. LV4 and
LV81 do not show any significant effect further indicating the
specific-specific effect.
Host responses are a key to intracellular killing or
multiplicity of Leishmania. Interestingly, supernatants of
postinfected 9-O-AcSAhigh promastigotes (K27, JSIH118,
L280 and MON29) demonstrate a negligible accumulation
of NO, indicating the effect of 9-O-AcSA in bestowing a
survival benefit (Figure 6(a)). In contrast supernatants from
de-O-acetylated 9-O-AcSAhigh promastigotes show increased
accumulation of NO further suggesting that 9-O-AcSA pro-
bably imparts a survival benefit, in the absence of which host
leihmanicidal responses are triggered.
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In leishmaniasis, production of a TH1 response surpass-
ing the TH2 response is beneficial to the host [49]. Post-
infection with de-O-acetylated 9-O-AcSAhigh promastigotes
demonstrate increased levels of IL-12 and IFN-γ, the signa-
ture TH1 cytokines (Figures 6(b) and 6(c)) indicating that
the effective modulation of the host responses affects the
leishmania biology via 9-O-AcSA acting as suitable ligands
whose expression supports parasite entry. This may be one
of the ways amongst many waiting to be explored.
10. Critical Evaluation and Perspective
The present scenario of leishmaniasis affecting millions in
different tropical and subtropical countries causes immea-
surable death and destruction. The increasing drug unre-
sponsiveness of these manipulative parasites and the advent
of several drug resistant clinical isolates have made the
situation graver. Differential distribution of SA in different
virulent Leishmania sp. shows enhanced 9-O-AcSA levels
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in-dicating a balance between total SA and the percent of
9-O-AcSA under different disease conditions which indicate
their probable association with the disease biology. In spite of
the presence of significant levels of sialic acids in the culture
medium, the minimal levels of SA and undetectable levels
of 9-O-AcSA on avirulent UR6 indicate that the avirulent
strain is unable to adsorb sialic acids from the environment
as efficiently as virulent AG83, which suggest a probable link
between this sugar and virulence. Additionally, the preferen-
tial adsorption of Neu5Gc by avirulent UR6 promastigotes in
contrast to virulent AG83 raises questions on the preferential
adsorption of this sugar by UR6 which paves the path for
future investigations. It may also be envisaged that these
acquired sialic acids could possibly fit within the well-defined
glycocalyx of the parasite but the mechanism remains to
be investigated. But whatever may be the consequencess it
would lead to a probable change in the surface architecture
that probably create newer sites of mimicry or recognition or
immunomodulation. Demonstration of distinct bands cor-
responding to different sialoglycoproteins also indicates that
probably the adsorbed sialic acids modify specific surface
molecules. However, due to the lack of sialic acid biosynthetic
machinery known the exact mechanism remains to be
investigated. Furthermore, identification of these specific
proteins by proteomic/glycoproteomic approaches on the
parasite surface bearing terminal 9-O-AcSA would open
up newer targets for exploiting parasite biology in future.
Additionally these parasite surface sialoglycoconjugates may
be harnessed for the production of sialoglycotope-specific
antibodies which could be effectively used. Present day
research for combating this disease involves the identification
and characterization of novel molecular markers that not
only controls parasite survival within host cells but also elicits
a favorable TH1 bias essential for the curative response.
The presence of 9-O-AcSA on virulent strains as compared
to their undetectable presence in avirulent strains suggests
their importance in virulence. Furthermore the possible in-
fluence of 9-O-AcSA in enhancing parasite entry within
macrophages, NO-resistance and host modulation suggests
their essential role in parasite biology. However, the direct as-
sociation of 9-O-AcSA with differentiation, multiplication,
and proliferation within macrophages requires detailed ex-
ploration of different facets of parasite biology. Whether
these acquired sialic acids change their conformation to form
a new set of molecules that play a crucial role in the in-
tracellular parasite biology is a matter of future research.
Moreover, the study needs to be extended in the in vivo
system which remains to be explored. Such studies are pre-
sently ongoing. Importantly, 9-O-AcSA would also help to
differentiate the strains based on their virulence interfering
in the outcome of the disease. However, elucidation of
the detailed mechanism influencing these facets requires
investigation. These observations also raise the possibility
that differential opsonization of pathogens using sialylated
glycoconjugatesmay possibly be a general phenomenon exer-
cised by many other parasites which will dictate the fu-
ture research and is likely to be promising. Moreover, since
these sialoglycotopes also occur in the metacyclic population
of virulent Leishmania sp. they will probably serve as im-
portant determinants for early detection of the infection.
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